- Home
- ELVN vs HE Comparison
ELVN vs HE Comparison
Compare ELVN & HE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- HE
- Stock Information
- Founded
- ELVN 2016
- HE 1891
- Country
- ELVN United States
- HE United States
- Employees
- ELVN N/A
- HE N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- HE Electric Utilities: Central
- Sector
- ELVN Health Care
- HE Utilities
- Exchange
- ELVN Nasdaq
- HE Nasdaq
- Market Cap
- ELVN 1.1B
- HE 1.2B
- IPO Year
- ELVN 2020
- HE N/A
- Fundamental
- Price
- ELVN $27.53
- HE $9.75
- Analyst Decision
- ELVN Strong Buy
- HE Hold
- Analyst Count
- ELVN 3
- HE 2
- Target Price
- ELVN $34.33
- HE $10.25
- AVG Volume (30 Days)
- ELVN 309.7K
- HE 6.3M
- Earning Date
- ELVN 11-07-2024
- HE 11-07-2024
- Dividend Yield
- ELVN N/A
- HE 14.77%
- EPS Growth
- ELVN N/A
- HE N/A
- EPS
- ELVN N/A
- HE N/A
- Revenue
- ELVN N/A
- HE $3,652,762,000.00
- Revenue This Year
- ELVN N/A
- HE $4.45
- Revenue Next Year
- ELVN N/A
- HE $1.35
- P/E Ratio
- ELVN N/A
- HE N/A
- Revenue Growth
- ELVN N/A
- HE N/A
- 52 Week Low
- ELVN $9.80
- HE $7.61
- 52 Week High
- ELVN $27.67
- HE $18.19
- Technical
- Relative Strength Index (RSI)
- ELVN 73.14
- HE 38.97
- Support Level
- ELVN $24.60
- HE $8.84
- Resistance Level
- ELVN $27.55
- HE $10.14
- Average True Range (ATR)
- ELVN 1.41
- HE 0.54
- MACD
- ELVN 0.40
- HE -0.05
- Stochastic Oscillator
- ELVN 98.56
- HE 23.21
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases. Its product candidates include ELVN-001 which is a potent, selective, small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with chronic myeloid leukemia, and the ELVN-002 which is central nervous system (CNS) penetrant and irreversible HER2 inhibitor with activity against wild type HER2 and various HER2 mutations.
About HE Hawaiian Electric Industries Inc.
Hawaiian Electric Industries is the parent company of three Hawaii-based regulated utilities and Hawaii's American Savings Bank. The utilities provide electricity on the five islands of Oahu, Hawaii, Maui, Molokai, and Lanai.